Logistics & Transportation

Articles

Plant targets Covid-19 vaccine supply for Israel, Europe and elsewhere

Mapi Pharma earmarks space for vaccine production facility

Originally developed by Ajinomoto for peptide synthesis, the technology has been expanded to include oligonucleotide production

FDA okays first commercial drug manufactured via AJIPHASE technology

Facility will up capacity and allow for more supply chain diversification

MilliporeSigma making headway on new membrane production plant

Pre-qualified 2-8°C shippers are designed for vaccines and biologics

New line of thermal packaging hits the market

Company scaling up manufacturing capacity and anticipates compatibility with its standard distribution channels

J&J and Europe agree on Janssen Covid-19 vaccine candidate, subject to regulatory okay

Optimizing supply chain by automating hospital restocking

Sandoz launches its first RFID-tagged critical injectable medicines

DARPA awards the funds for new continuous manufacturing technology

Continuity Pharma scores $1.5 million development grant

Michael Christel is Group Managing Editor of Pharmaceutical Commerce, Pharmaceutical Executive, and Applied Clinical Trials. He can be reached at mchristel@mjhlifesciences.com.

One expert's take on the key issues at stake

A regulatory view on Covid-19 vaccine outlook

2020 Pharma Traceability Vendor Directory

Move anticipates high-volume Covid-19 vaccine and therapeutics production, amidst other vial-production advances

Manufacturing & Packaging